...
首页> 外文期刊>Tumour biology : >A functional variant at miR-34a binding site in toll-like receptor 4 gene alters susceptibility to hepatocellular carcinoma in a Chinese Han population
【24h】

A functional variant at miR-34a binding site in toll-like receptor 4 gene alters susceptibility to hepatocellular carcinoma in a Chinese Han population

机译:Toll样受体4基因miR-34a结合位点的功能性变异改变了中国汉族人群对肝细胞癌的敏感性

获取原文
获取原文并翻译 | 示例
           

摘要

Toll-like receptor 4 (TLR4) plays a key role in prompting the innate or immediate response. A growing body of evidence suggests that genetic variants of TLR4 gene were associated with the development of cancers. This study aimed to investigate the relationship of a functional variant (rs1057317) at microRNA-34a (miR-34a) binding site in toll-like receptor 4 gene and the risk of hepatocellular carcinoma. A single center-based case-control study was conducted. In this study, the polymerase chain reaction (PCR) and direct sequencing were used to genotype sequence variants of TLR4 in 426 hepatocellular carcinoma cases and 438 controls. The modification of rs1057317 on the binding of hsa-miR-34a to TLR4 messenger RNA (mRNA) was measured by luciferase activity assay. Individuals carrying the AA genotypes for the rs1057317 were associated significantly with increased risk of hepatocellular carcinoma comparing with those carrying wild-type homozygous CC genotypes (adjusted odds ratio [OR] by sex and age, from 1.116 to 2.452, P=0.013). The activity of the reporter vector was lower in the reporter vector carrying C allele than the reporter vector carrying A allele. Furthermore, the expression of TLR4 was detected in the peripheral blood mononucleated cell of hepatocellular carcinoma (HCC) patients, suggesting thatmRNA and protein levels of TLR4 might be associated with SNP rs1057317. Collectively, these results suggested that the risk of hepatocellular carcinoma was associated with a functional variant at miR-34a binding site in toll-like receptor 4 gene. miR-34a/TLR4 axis may play an important role in the development of hepatocellular carcinoma.
机译:Toll样受体4(TLR4)在促进先天或立即反应中起关键作用。越来越多的证据表明,TLR4基因的遗传变异与癌症的发展有关。这项研究旨在调查在收费样受体4基因microRNA-34a(miR-34a)结合位点的功能性变体(rs1057317)与肝细胞癌风险之间的关系。进行了一项基于中心的病例对照研究。在这项研究中,聚合酶链反应(PCR)和直接测序被用来对426例肝细胞癌和438例对照的TLR4序列变异进行基因分型。通过荧光素酶活性测定法测量rs1057317对hsa-miR-34a与TLR4信使RNA(mRNA)结合的修饰。携带rs1057317的AA基因型的个体与携带野生型纯合CC基因型的个体相比,与肝细胞癌的风险显着相关(按性别和年龄调整的优势比[OR]从1.116到2.452,P = 0.013)。在携带C等位基因的报告载体中,报告载体的活性低于携带A等位基因的报告载体。此外,在肝细胞癌(HCC)患者的外周血单核细胞中检测到TLR4的表达,这表明TLR4的mRNA和蛋白水平可能与SNP rs1057317有关。总的来说,这些结果表明,肝细胞癌的风险与toll样受体4基因中miR-34a结合位点的功能变异有关。 miR-34a / TLR4轴可能在肝细胞癌的发展中起重要作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号